Analytical approaches to the diagnosis and treatment of aging and aging-related disease: Redox status and proteomics

Free Radical Research

Volumn 49, Issue 5, 2015, Pages 511-524

  Calabrese, V ^a   Dattilo, S ^a,b   Petralia, A ^a   Parenti, R ^a   Pennisi, M ^a   Koverech, G ^a   Graziano, A ^a   Monte, I ^a   Maiolino, L ^a   Ferreri, T ^b   Calabrese, E J ^c  

^a UNIVERSITY OF CATANIA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Aging; Glutathione; Neurodegenerative disorders; Proteomics; Redox homeostasis

Indexed keywords

GLUTATHIONE; TYROSINE; 3-NITROTYROSINE; BIOLOGICAL MARKER; PROTEIN;

AGING; ARTICLE; CHEMICAL MODIFICATION; GEL; GERIATRIC DISORDER; GLUTATHIONYLATION; HOMEOSTASIS; HORMESIS; HUMAN; LIPID PEROXIDATION; LIPID PEROXIDATION ADDUCT; MASS SPECTROMETRY; METABOLOMICS; NITRATION; PHENOTYPE; PROTEIN CARBONYLATION; PROTEIN PROCESSING; PROTEOMICS; REDOX HOMEOSTASIS; AGE; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DISEASE PREDISPOSITION; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR;

AGE FACTORS; AGING; ANIMALS; BIOMARKERS; DISEASE SUSCEPTIBILITY; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROTEIN CARBONYLATION; PROTEINS; PROTEOMICS; RISK FACTORS; TYROSINE;

EID: 84929145845     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2015.1020799     Document Type: Article

References (131)

1. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 1993; 2:366: 461-464.
2. Judy ME, Nakamura A, Huang A, Grant H, McCurdy H, Weiberth KF, et al. A shift to organismal stress resistance in programmed cell death mutants. PLoS Genet 2013; 9: e1003714.
3. Nkuipou-Kenfack E, Koeck T, Mischak H, Pich A, Schanstra JP, Zürbig P, Schumacher B. Proteome analysis in the assessment of ageing. Ageing Res Rev 2014; 18: 74-85.
4. Nkuipou-Kenfack E, Duranton F, Gayrard N, Argil é s À, Lundin U, Weinberger KM, et al. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease. PLoS One 2014; 9: e96955.
5. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 2013; 75: 685-705.
6. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013; 153: 1194-1217.
7. Schanstra J P, Mischak H. Proteomic urinary biomarker approach in renal disease: from discovery to implementation. Pediatr Nephrol 2014. [Epub ahead of print]
8. Calabrese V, Scapagnini G, Davinelli S, Koverech G, Koverech A, De Pasquale C, et al. Sex hormonal regulation and hormesis in aging and longevity: role of vitagenes. J Cell Commun Signal 2014. [Epub ahead of print]
9. Groh KJ, Suter MJ. Stressor-induced proteome alterations in zebrafish: a meta-analysis of response patterns. Aquat Toxicol 2015; 159C: 1-12.
10. Groh KJ, Nesatyy VJ, Segner H, Eggen RIL, Suter MJ-F. Global proteomics analysis of testis and ovary in adult zebrafish (Danio rerio). Fish Physiol Biochem 2011; 37: 619-647.
11. Schwanhaeusser B, Busse D, Li N, Dittmar G, Schuchhardt J. Wolf J, et al. Global quantification of mammalian gene expression control. Nature 2011; 473: 337-342.
12. Li J, Liu D, Sun L, Lu Y, Zhang Z. Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. J Neurol Sci 2012; 15;317: 1-5.
13. Silvestre F, Gillardin V, Dorts J. Proteomics to assess the role of phenotypicplasticity in aquatic organisms exposed to pollution and global warming. Integr Comp Biol 2012; 52: 681-694.
14. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997; 272: 20313-20316.
15. Hill BG, Bhatnagar A. Protein S-glutathiolation: redox-sensitive regulation of protein function. J Mol Cell Cardiol 2012; 52: 559-567.
16. Shelton MD, Mieyal JJ. Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases. Mol Cell 2008; 25: 332-346.
17. Baek JY, Han SH, Sung SH, Lee HE, Kim YM, Noh YH, et al. Sulfiredoxin protein is critical for redox balance and survival of cells exposed to low steady-state levels of H2O2. J Biol Chem 2012; 2:287: 81-89.
18. Ghezzi P. Protein glutathionylation in health and disease. Biochim Biophys Acta 2013; 1830: 3165-3172.
19. Dalle-Donne I, Colombo G, Gagliano N, Colombo R, Giustarini D, Rossi R, Milzani A. S-glutathiolation in life and death decisions of the cell. Free Radic Res 2011; 45: 3-15.
20. Aesif SW, Janssen-Heininger YM, Reynaert NL. Protocols for the detection of S-glutathionylated and S-nitrosylated proteins in situ. Methods Enzymol 2010; 474: 289-296.
21. Popov D Protein S-glutathionylation: from current basics to targeted modifications. Arch Physiol Biochem 2014; 120: 123-130.
22. Yan LJ. Protein redox modification as a cellular defense mechanism against tissue ischemic injury. Oxid Med Cell Longev 2014; 34: 31-54.
23. Petrini S, Passarelli C, Pastore A, Tozzi G, Coccetti M, Colucci M, et al. Protein glutathionylation in cellular compartments: a constitutive redox signal. Redox Rep 2012; 17: 63-71.
24. Coppo L, Ghezzi P. Thiol regulation of pro-inflammatory cytokines and innate immunity: protein S-thiolation as a novel molecular mechanism. Biochem Soc Trans 2011; 39: 1268-1272.
25. Das KC, Muniyappa H. c-Jun-NH2 terminal kinase (JNK)- mediates AP-1 activation by thioredoxin: phosphorylation of cJun, JunB, and Fra-1. Mol Cell Biochem 2010; 337: 53-63.
26. Hashemy SI, Johansson C, Berndt C, Lillig CH, Holmgren A. Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: effects on structure and activity. J Biol Chem 2007; 282: 14428-14436.
27. Michelet L, Zaffagnini M, Morisse S, Sparla F, P é rez-P é rez ME, Francia F, et al. Redox regulation of the Calvin-Benson cycle: something old, something new. Front Plant Sci 2013; 4: 470.
28. Giustarini D, Milzani A, Aldini G, Carini M, Rossi R, Dalle-Donne I. S-nitrosation versus S-glutathionylation of protein sulfhydryl groups by S-nitrosoglutathione. Antioxid Redox Signal 2005; 7: 930-939.
29. Cotgreave IA, Gerdes R, Schuppe-Koistinen I, Lind C. S-glutathionylation of glyceraldehyde-3-phosphate dehydrogenase: role of thiol oxidation and catalysis by glutaredoxin. Methods Enzymol 2002; 348: 175-182.
30. Klatt P, Lamas S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 2000; 267: 4928-4944.
31. Ravichandran V, Seres T, Moriguchi T, Thomas JA, Johnston RB Jr. S-thiolation of glyceraldehyde-3-phosphate dehydrogenase induced by the phagocytosis-associated respiratory burst in blood monocytes. J Biol Chem 1994; 269: 25010-25015.
32. Klatt P, Molina EP, De Lacoba MG, Padilla CA, Martinez-Galesteo E, Barcena JA, Lamas S. Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J 1999; 13: 1481-1490.
33. Borges CR, Geddes T, Watson JT, Kuhn DM. Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylast inhibition during oxidative stress. J Biol Chem 2002; 277: 48295-48302.
34. Garcia-Garcia A, Zavala-Flores L, Rodriguez-Rocha H, Franco R. Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease. Antioxid Redox Signal 2012; 17: 1764-1784.
35. Bachi A, Dalle-Donne I, Scaloni A. Redox proteomics: chemical principles, methodological approaches and biological/ biomedical promises. Chem Rev 2013; 113: 596-698.
36. Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, et al. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. J Biol Chem 2003; 278: 42588-42595.
37. Dalle-Donne I, Rossi R, Giustarini D, Colombo R, Milzani A. S-glutathionylation in protein redox regulation. Free Radic Biol Med 2007; 43: 883-898.
38. Pineda-Molina E, Klatt P, Vazquez J, Marina A, Garcia de Lacoba M, Perez-Sala D, et al. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redoxinduced inhibition of DNA binding. Biochemistry 2001; 40: 14134-14142.
39. Carletti B, Passarelli C, Sparaco M, Tozzi G, Pastore A, Bertini E, et al. Effect of protein glutathionylation on neuronal cytoskeleton: a potential link to neurodegeneration. Neuroscience 2011; 192: 285-294.
40. Giustarini D, Dalle-Donne I, Lorenzini S, Milzani A, Rossi R. Age-related influence on thiol, disulfide, and protein-mixed disulfide levels in human plasma. J Gerontol A Biol Sci Med Sci 2006; 61: 1030-1038.
41. Rebrin I, Bayne AC, Mockett RJ, Orr WC, Sohal RS. Free aminothiols, glutathione redox state and protein mixed disulphides in aging Drosophila melanogaster. Biochem J 2004; 382: 131-136.
42. Perluigi M, Di Domenico F, Giorgi A, Schinin à ME, Coccia R, Cini C, et al. Redox proteomics in aging rat brain: involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process. J Neurosci Res 2010; 88: 3498-3507.
43. Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med 2004; 10: S18-25.
44. Newman SF, Sultana R, Perluigi M, Coccia R, Cai J, Pierce WM, et al. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach. J Neurosci Res 2007; 85: 1506-1514.
45. Anathy V, Roberson EC, Guala AS, Godburn KE, Budd RC, Janssen-Heininger YM. Redox-based regulation of apoptosis: S-glutathionylation as a regulatory mechanism to control cell death. Antioxid Redox Signal 2012; 16: 496-505.
46. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res 1994; 54: 1969s-1975s.
47. Fisher-Wellman KH, Gilliam LA, Lin CT, Cathey BL, Lark DS, Neufer PD. Mitochondrial glutathione depletion reveals a novel role for the pyruvate dehydrogenase complex as a key H2O2-emitting source under conditions of nutrient overload. Free Radic Biol Med 2013; 65: 1201-1208.
48. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 2000; 62: 649-671.
49. Peterson DR, Sukowski EJ, Zikos D. Blood-brain barrier transport pathways for cytoprotective thiols. Am J Ther 2013; 20: 469-479.
50. Maybodi L, Pow DV, Kharazia VN, Weinberg RJ. Immunocytochemical demonstration of reduced glutathione in neurons of rat forebrain. Brain Res 1999; 817: 199-205.
51. Janaky R, Shaw CA, Oja SS, Saransaari P. Taurine release in developing mouse hippocampus is modulated by glutathione and glutathione derivatives. Amino Acids 2008; 34: 75-80.
52. Samuelsson M, Vainikka L, Ollinger K. Glutathione in the blood and cerebrospinal fluid: a study in healthy male volunteers. Neuropeptides 2011; 45: 287-292.
53. Bharath S, Andersen JK. Glutathione depletion in a midbrain- derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease. Antioxid Redox Signal 2005; 7: 900-910.
54. Martinez M, Ferrandiz ML, Diez A, Miquel J. Depletion of cytosolic GSH decreases the ATP levels and viability of synaptosomes from aged mice but not from young mice. Mech Ageing Dev 1995; 84: 77-81.
55. Schulz JB, Lindenau J, Seyfried J, Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000; 267: 4904-4911.
56. Kannan R, Mittur A, Bao Y, Tsuruo T, Kaplowitz N. GSH transport in immortalized mouse brain endothelial cells: evidence for apical localization of a sodium-dependent GSH transporter. J Neurochem 1999; 73: 390-399.
57. Perluigi M, Joshi G, Sultana R, Calabrese V, De Marco C, Coccia R, et al. In vivo protection by the xanthate tricyclodecan- 9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress. Neuroscience 2006; 138: 1161-1170.
58. Sultana R, Newman SF, Abdul HM, Cai J, Pierce WM, Klein JB, et al. Protective effect of D609 against amyloid-beta1- 42-induced oxidative modification of neuronal proteins: redox proteomics study. J Neurosci Res 2006; 84: 409-417.
59. Wilkins MR, Pasquali C, Appel RD, Ou K, Golaz O, Sanchez JC, et al. From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (NY) 1996; 14: 61-65.
60. Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat Biotechnol 2003; 21: 255-261.
61. Zhou H, Watts JD, Aebersold R. A systematic approach to the analysis of protein phosphorylation. Nat Biotechnol 2001; 19: 375-378.
62. Chakravarti B, Chakravarti DN. Oxidative modification of proteins: age-related changes. Gerontology 2007; 53: 128-139.
63. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160: 1-40.
64. Butterfield DA, Abdul HM, Newman S, Reed T. Redox proteomics in some age-related neurodegenerative disorders or models thereof. NeuroRx 2006; 3: 344-357.
65. Butterfield DA, Sultana R. Redox proteomics: understanding oxidative stress in the progression of age-related neurodegenerative disorders. Expert Rev Proteomics 2008; 5: 157-160.
66. Butterfield DA, Perluigi M, Reed T, Muharib T, Hughes CP, Robinson RA, et al. Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. Antioxid Redox Signal 2012; 17: 1610-1655.
67. Stadtman ER, Levine RL. Chemical modification of proteins by reactive oxygen species. In: Dalle-Donne I, Scaloni A, Butterfield A (eds.). Redox proteomics: from protein modifications to cellular dysfunction and diseases. Hoboken, NJ: John Wiley & Sons Inc.; 2006. pp 3-23.
68. Colzani M, Aldini G, Carini M. Mass spectrometric approaches for the identification and quantification of reactive carbonyl species protein adducts. J Proteomics 2013; 92: 28-50.
69. Colzani M, Criscuolo A, De Maddis D, Garzon D, Yeum KJ, Vistoli G, et al. A novel high resolution MS approach for the screening of 4-hydroxy-trans-2-nonenal sequestering agents. J Pharm Biomed Anal 2014; 91: 108-118.
70. Baraibar MA, Ladouce R, Friguet B. Proteomic quantification and identification of carbonylated proteins upon oxidative stress and during cellular aging. J Proteomics 2013; 92: 63-70.
71. Guerrero E, Vasudevaraju P, Hegde ML, Britton GB, Rao KS. Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease. Mol Neurobiol 2013; 47: 525-536.
72. Baynes JW, Gillery P. Frontiers in research on the Maillard reaction in aging and chronic disease. Clin Chem Lab Med 2014; 52: 1-3.
73. Butterfield DA, Castegna A, Lauderback CM, Drake J. Evidence that amyloid β-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 2002; 23: 655-664.
74. Shichiri M. The role of lipid peroxidation in neurological disorders. J Clin Biochem Nutr 2014; 54: 151-160.
75. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J Neurochem 1997; 68: 255-264.
76. Subramaniam R, Roediger F, Jordan B, Mattson MP, Keller JN, Waeg G, et al The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. J Neurochem 1997; 69: 1161-1169.
77. Sultana R, Butterfield DA. Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease. Methods Mol Biol 2009; 566: 123-135.
78. Reed TT. Lipid peroxidation and neurodegenerative disease. Free Radic Biol Med 2011; 51: 1302-1319.
79. Markesbery WR, Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 1998; 19: 33-36.
80. Groitl, B. Jakob, U. Thiol-based redox switches. Biochim Biophys Acta 2014; 1844: 1335-1343.
81. Ghezzi, P. Oxidoreduction of protein thiols in redox regulation. Biochem Soc Trans 2005; 33: 1378-1381.
82. Giustarini D, Rossi R, Milzani A, Colombo R, Dalle-Donne I. S-glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med 2004; 8: 201-212.
83. Grune T, Reinheckel T, Davies KJ. Degradation of oxidized proteins in mammalian cells. FASEB J 1997; 11: 526-534.
84. Sheehan D. Detection of redox-based modification in twodimensional electrophoresis proteomic separations. Biochem Biophys Res Commun 2006; 349: 455-462.
85. Ghezzi P. Regulation of protein function by glutathionylation. Free Radic Res 2005; 39: 573-580.
86. Petrushanko IY, Yakushev S, Mitkevich VA, Kamanina YV, Ziganshin RH, Meng X, et al. S-Glutathionylation of the Na, k-atpase catalytic subunit is a determinant of the enzyme redox sensitivity. J Biol Chem 2012; 287: 32195-32205.
87. Fratelli M, Demol H, Puype M, Casagrande S, Eberini I, Salmona M, et al. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human t lymphocytes. Proc Natl Acad Sci USA 2002; 99: 3505-3510.
88. Cabiscol E, Levine RL. The phosphatase activity of carbonic anhydrase III is reversibly regulated by glutathiolation. Proc Natl Acad Sci USA 1996; 93: 4170-4174.
89. Davis DA, Newcomb FM, Starke DW, Ott DE, Mieyal JJ, Yarchoan R. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J Biol Chem 1997; 272: 25935-25940.
90. Liang JN, Pelletier MR. Destabilization of lens protein conformation by glutathione mixed disulfide. Exp Eye Res 1988; 47: 17-25.
91. Ahsan H. 3-Nitrotyrosine: a biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions. Hum Immunol 2013; 74: 1392-1399.
92. Ghezzi P, Bonetto V. Redox proteomics: identification of oxidatively modified proteins. Proteomics 2003; 3: 1145-1153.
93. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 2003; 85: 1394-1401.
94. Sultana R, Perluigi M, Butterfield DA. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid Redox Signal 2006; 8: 2021-2037.
95. Chait BT. Chemistry. Mass spectrometry: bottom-up or topdown? Science 2006; 314: 65-66.
96. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250: 4007-4021.
97. Butterfield DA, Perluigi M, Sultana R. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol 2006; 545: 39-50.
98. Wittmann-Liebold B, Graack HR, Pohl T. Two-dimensional gelelectrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics 2006; 6: 4688-4703.
99. Kim H, Eliuk S, Deshane J, Meleth S, Sanderson T, Pinner A, et al. 2D gel proteomics: An approach to study age-related differences in protein abundance or isoform complexity in biological samples. Methods Mol Biol 2007; 371: 349-391.
100. Sheehan D, McDonagh B, Barcena JA. Redox proteomics. Expert Rev Proteomics 2010; 7: 1-4.
101. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997; 18: 2071-2077.
102. Gharbi S, Gaffney P, Yang A, Zvelebil MJ, Cramer R, Waterfield MD, et al. Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics 2002; 1: 91-98.
103. Timms JF, Cramer R. Difference gel electrophoresis. Proteomics 2008; 8: 4886-4897.
104. Moruz L, Pichler P, Stranzl T, Mechtler K, Kall L. Optimized nonlinear gradients for reversed-phase liquid chromatography in shotgun proteomics. Anal Chem 2013; 85: 7777-7785.
105. Schirmer EC, Yates JR III, Gerace L. MudPIT: a powerful proteomics tool for discovery. Discov Med 2003; 3: 38-39.
106. Maes K, Smolders I, Michotte Y, Van Eeckhaut A. Strategies to reduce aspecific adsorption of peptides and proteins in liquid chromatography-mass spectrometry based bioanalyses: an overview. J Chromatogr A 2014; 1358: 1-13.
107. Stalmach A, Albalat A, Mullen W, Mischak H. Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications. Electrophoresis 2013; 34: 1452-1464.
108. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009; 27: 633-641.
109. Lindemann C, Leichert LI. Quantitative redox proteomics: the NOxICAT method. Methods Mol Biol 2012; 893: 387-403.
110. Thompson A, Schafer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem 2003; 75: 1895-1904.
111. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, et al. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006; 441: 513-517.
112. Murray CI, Uhrigshardt H, O'Meally RN, Cole RN, Van Eyk JE. Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay. Mol Cell Proteomics 2012; 11:M111. 013441.
113. Madian AG, Regnier FE. Proteomic identification of carbonylated proteins and their oxidation sites. J Proteome Res 2010; 9: 3766-3780.
114. Palmese A, De Rosa C, Marino G, Amoresano A. Dansyl labeling and bidimensional mass spectrometry to investigate protein carbonylation. Rapid Commun Mass Spectrom 2011; 25: 223-231.
115. Mischak H, Vlahou A, Ioannidis JP. Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience. Clin Biochem 2013; 46: 432-443.
116. Bogdanov B, Smith RD. Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrom Rev 2005; 24: 168-200.
117. McLafferty FW, Horn DM, Breuker K, Ge Y, Lewis MA, Cerda B, et al. Electron capture dissociation of gaseous multiply charged ions by Fourier-transform ion cyclotron resonance. J Am Soc Mass Spectrom 2001; 12: 245-249.
118. Meng F, Forbes AJ, Miller LM, Kelleher NL. Detection and localization of protein modifications by high resolution tandem mass spectrometry. M ass Spectrom Rev 2005; 24:126-134.
119. Zhai H, Xuemei H, Breuker K, McLafferty FW. Consecutive ion activation for top down mass spectrometry: improved protein sequencing by nozzle-skimmer dissociation. Anal Chem 2005; 77: 5777-5784.
120. Claudino WM, Quattrone A, Biganzoli L, Pestrin M, Bertini I, Di Leo A. Metabolomics: available results, current research projects in breast cancer and future applications. J Clin Oncol 2007; 25: 2840-2846.
121. WikoffWR, Gangoiti JA, Barshop BA, Siuzdak G. Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem 2007; 53: 2169-2176.
122. Ross BM, Moszczynska A, Erlich J, Kish SJ. Phospholipidmetabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity. J Neurochem 1998; 70: 786-793.
123. Han X, M Holtzman D, McKeel DW Jr, Kelley J, Morris JC. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 2002; 82: 809-818.
124. Kogan NM, Mechoulam R. Cannabinoids in health and disease. Dialogues Clin Neurosci 2007; 9: 413-430.
125. Martín-Moreno AM, Reigada D, Ramírez BG, Mechoulam R, Innamorato N, Cuadrado A, et al. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Mol Pharmacol 2011; 79: 9 64-9 73.
126. Calabrese EJ, Iavicoli I, Calabrese V. Hormesis: why it is important to biogerontologists. Biogerontology 2012; 13: 215-235.
127. Edrey YH, Oddo S, Cornelius C, Caccamo A, Calabrese V, Buffenstein R. Oxidative damage and amyloid- βmetabolism in brain regions of the longest-lived rodents. J Neurosci Res 2014; 92: 195-205.
128. Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP. Cellular stress responses, the hormesis paradigm and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal 2010; 13: 1763-1811.
129. Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova-Kostova AT, Butterfield DA. Nitric oxide in cell survival: a Janus molecule. Antioxid Redox Signal 2009; 11: 2717-2739.
130. Poon HF, Calabrese V, Calvani M, Butterfield DA. Proteomics analyses of specific protein oxidation and protein expression in aged rat brain and its modulation by L-acetylcarnitine: insights into the mechanisms of action of this proposed therapeutic agent for CNS disorders associated with oxidative stress. Antioxid Redox Signal 2006; 8: 381-394.
131. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 2007; 8: 766-775.